News reporting · ABC News Australia · 2022-07-20

Sunscreen reduces the amount of UVB that reaches skin. In the Australian Sun-D trial, people assigned to use SPF50+ on days when the UV index was forecast to reach 3 or higher were more likely to have low blood vitamin D after a year than those using sunscreen as usual. Cancer Council Australia continued to recommend sun protection.

ABC News followed the launch of a year-long study of SPF50+ sunscreen and vitamin D levels.

ABC News reported in July 2022 that researchers in Australia were recruiting for a trial of sunscreen use and vitamin D. Volunteers would either use the supplied sunscreen regularly or continue their usual sun-protection routine.

Participants would answer monthly surveys and give three blood samples across a year. The team sought volunteers from four eastern states, allowing it to study people living at different latitudes.

Vitamin D3 for Life commentary

Why might a daily-use trial differ from a laboratory sunscreen test?

A controlled test can define the amount applied and the UV exposure. A daily-use trial measures the net effect of a regimen in everyday life. Time outdoors, clothing and how consistently sunscreen is applied are part of that comparison.

The ABC story followed recruitment in 2022. In 2025, the researchers reported that vitamin D levels rose less in the group assigned to routine SPF50+ use than in the group following its usual sun-protection routine. The adjusted difference was 5.2 nmol/L. The investigators continue to recommend sun protection. The NHS explains how shade, clothing and sunscreen can be used together.